Sign in

CIK 0001727196

  • Non-accelerated filer

Scholar Rock Holding Corp

Sign in to watch
Ticker
SRRK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823750435
Phone
+1 857-259-3860
Business address
301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
  1. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 8,484 shares at an average $47.07 ($399,351)
  2. 4 Open-market sale CHIEF MEDICAL OFFICER sold 4,157 shares at $46.53 ($193,418)
  3. 4 Open-market sale GENERAL COUNSEL sold 9,580 shares at $46.53 ($445,740)
  4. 4 Open-market sale CHRO sold 9,035 shares at $46.53 ($420,382)
  5. 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 7,989 shares at $46.53 ($371,714)
  6. 4 Grant or award President of R&D acquired 47,021 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 47,021 shares (grant or award)
  8. 4 Grant or award Chief Scientific Officer acquired 29,258 shares (grant or award)
  9. 4 Grant or award Chief Human Resources Officer acquired 29,258 shares (grant or award)
  10. 4 Grant or award Chief Medical Officer acquired 34,482 shares (grant or award)
  11. 4 Grant or award General Counsel acquired 36,572 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 128,004 shares (grant or award)
  13. 4 Grant or award Chief Operating Officer acquired 47,021 shares (grant or award)
  14. 4 Option exercise 10% owner acquired 1,575,008 shares (option exercise)
  15. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 14,898 shares at an average $46.71 ($695,938)
  16. 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 8,406 shares at $44.48 ($373,880)
  17. 4 Open-market sale CHRO sold 6,600 shares at $44.48 ($293,553)
  18. 4 Open-market sale CHIEF MEDICAL OFFICER sold 5,798 shares at $44.48 ($257,882)
  19. 4 Open-market sale GENERAL COUNSEL sold 8,016 shares at $44.48 ($356,533)
  20. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 13,112 shares at $45.20 ($592,611)

Page 2 of 17 · 321 filings